Melanoma News

Timing of melanoma diagnosis, treatment critical to survival - Science Daily



Timing of melanoma diagnosis, treatment critical to survival 
Science Daily
A new Cleveland Clinic study underscores the importance of early detection and treatment of melanoma, the deadliest form of skin cancer. The research, published online in the Journal of the American Academy of Dermatology, indicates that the sooner ...

and more » 


Utah Has The Country's Highest Rate Of Melanoma - RadioWest



RadioWest
 
Utah Has The Country's Highest Rate Of Melanoma 
RadioWest
In 2014, about 21 out of every 100,000 Americans was diagnosed with melanoma. In Utah, it's 42 out of every 100,000 people. Joelle Fierro with the state's Cancer Control Network says Utah has consistently had higher-than-average melanoma rates, but ...

 


Opdivo Receives Priority Review for Advanced Melanoma - Specialty Pharmacy Times (blog)



Pharmaceutical Processing
 
Opdivo Receives Priority Review for Advanced Melanoma 
Specialty Pharmacy Times (blog)
Bristol-Myers Squibb recently announced that the supplemental biologics license application (sBLA) for nivolumab (Opdivo) was accepted by the FDA for advanced melanoma with a high risk of recurrence after surgery, according to a press release.
FDA grants priority review to Opdivo for resected, high-risk melanoma Healio
FDA Grants Priority Review For Opdivo In Patients With Advanced Melanoma Pharmaceutical Processing
Bristol-Myers Gets Priority Review for Opdivo Label Expansion Nasdaq
The Wall Street Transcript  -Zacks Investment Research 
all 230 news articles » 


Targeting NRAS Mutations in Metastatic Melanoma - OncLive



Targeting NRAS Mutations in Metastatic Melanoma 
OncLive
Panelists: Jeffrey S. Weber, MD, PhD, NYU Langone Health; Reinhard G. Dummer, MD, University Hospital of Zurich; Axel Hauschild, MD, PhD, University Hospital Schleswig-Holstein; Michael A. Postow, MD, Memorial Sloan Kettering Cancer Center; ...

and more » 


Insurance determines melanoma surgery decision: Study - UPI.com - UPI.com



UPI.com
 
Insurance determines melanoma surgery decision: Study - UPI.com 
UPI.com
Surgery is the main treatment for melanoma -- a form of skin cancer -- but insurance may affect whether that cancer is quickly removed, research suggests.

and more » 


Why so many Utah men have melanoma | Deseret News - Deseret News



Deseret News
 
Why so many Utah men have melanoma | Deseret News 
Deseret News
Utah has the highest rates of melanoma in the U.S. ? and men in Summit County have the highest rates in Utah. Are there steps we can take to reverse this ...
Non-Melanoma Skin Cancer Treatment Market Competitive ... MilTech

all 2 news articles » 


Long-term Survival From Ipilimumab/Nivolumab Combination in Metastatic Melanoma - Cancer Therapy Advisor



Cancer Therapy Advisor
 
Long-term Survival From Ipilimumab/Nivolumab Combination in Metastatic Melanoma 
Cancer Therapy Advisor
Accumulating data from long-term follow up of patients with metastatic melanoma treated with the ipilimumab and nivolumab combination demonstrate unprecedented survival at 3 years. With at least 36 months of follow-up for all patients, Wolchok et al ...

 


Data in Melanoma: Observing Trials and Unmet Needs - OncLive - OncLive



OncLive
 
Data in Melanoma: Observing Trials and Unmet Needs - OncLive 
OncLive
Jeffrey S. Weber, MD, PhD; Caroline Robert, MD, PhD; Michael A. Postow, MD; Reinhard G. Dummer, MD; and Axel Hauschild, MD, PhD, discuss prospective ...

and more » 


Scientists pinpoint surprising origin of melanoma - Medical Xpress - Medical Xpress



Medical Xpress
 
Scientists pinpoint surprising origin of melanoma - Medical Xpress 
Medical Xpress
Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin ...

and more » 


Challenges Remain in Melanoma Treatment, Expert Says - Curetoday.com



Curetoday.com
 
Challenges Remain in Melanoma Treatment, Expert Says 
Curetoday.com
In an interview with CURE at the 7th European Post-Chicago Melanoma/Skin Cancer Meeting Ross, Charles M. McBride Distinguished Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, ...